subject area of
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement Academic Article
- Anticoagulant therapy following acute myocardial infarction. Part I. Incidence of and factors predisposing to thromboembolism associated with acute myocardial infarction. Academic Article
- Anticoagulants in pregnancy: A review of indications and complications Academic Article
- Anticoagulation therapy in 2015: where we are and where we are going Academic Article
- Apixaban in Patients with Atrial Fibrillation Academic Article
- Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope Academic Article
- Berzelius Symposium 93: International Conference on Thrombosis and Embolism Academic Article
- Cholesterol microembolization syndrome Academic Article
- Clinical pathologic conference Academic Article
- Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol Academic Article
- Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials Academic Article
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Academic Article
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial Academic Article
- Coronary Atheroembolism Academic Article
- D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Academic Article
- Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation Academic Article
- Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial Academic Article
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation Academic Article
- Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
- Definition of high risk/high response population for stroke in patients with transient ischemic attacks. Academic Article
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies Academic Article
- Disseminated Tumor Embolism From Breast Cancer Leading to Multiorgan Failure Academic Article
- Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation? Academic Article
- Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT Academic Article
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation Academic Article
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation Academic Article
- Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study Academic Article
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
- Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
- Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score Academic Article
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation Academic Article
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry Academic Article
- Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation Academic Article
- Heparin-induced thrombocytopenia: a historical perspective Academic Article
- How Should Results from Completed Studies Influence Ongoing Clinical Trials? Academic Article
- Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation Academic Article
- Influence of low-intensity warfarin treatment on patients' perceptions of quality of life Academic Article
- Intra-arterial low-dose streptokinase infusion for superior mesenteric artery embolus. Academic Article
- Investigation of the Mechanism of False Positive125I-Labelled Fibrinogen Scans Academic Article
- Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation Academic Article
- Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial Academic Article
- Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation Academic Article
- Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation Academic Article
- Myocardial infarction size from serial CPK: variability of CPK serum entry ratio with size and model of infarction. Academic Article
- Newly Identified Events in the RE-LY Trial Academic Article
- Perioperative myocardial infarction caused by atheroembolism. Academic Article
- Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
- RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT Academic Article
- Renal lesions and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits. Academic Article
- Response to Letter Regarding Article “Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events” Academic Article
- Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation Academic Article
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES Academic Article
- Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Academic Article
- Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS) Academic Article
- Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease Academic Article
- Subclinical Atrial Fibrillation and the Risk of Stroke Academic Article
- Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events Academic Article
- The Challenge of Timing Surgery in a Complex Case of Endocarditis Academic Article
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Academic Article
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
- The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics Academic Article
- The cost and benefit of prophylaxis against deep vein thrombosis in elective hip replacement. DVT/PE Prophylaxis Consensus Forum. Academic Article
- Thrombosis and embolism in pediatric cardiomyopathy Academic Article
- Utilization of fogarty arterial embolectomy catheter in urethral diverticulectomy Academic Article
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries Academic Article
- Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial Academic Article
- Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility Academic Article
- ‘Real world’ use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry Academic Article